Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors.

Khanna G, Bushnell D, O'Dorisio MS.

Oncologist. 2008 Apr;13(4):382-9. doi: 10.1634/theoncologist.2007-0175. Review.

2.

Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors.

Taïeb D, Garrigue P, Bardiès M, Abdullah AE, Pacak K.

PET Clin. 2015 Oct;10(4):477-86. doi: 10.1016/j.cpet.2015.06.001. Epub 2015 Jul 8. Review.

3.

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.

Breeman WA, de Jong M, Kwekkeboom DJ, Valkema R, Bakker WH, Kooij PP, Visser TJ, Krenning EP.

Eur J Nucl Med. 2001 Sep;28(9):1421-9. Review.

PMID:
11585303
4.

Peptide receptor imaging and therapy.

Kwekkeboom D, Krenning EP, de Jong M.

J Nucl Med. 2000 Oct;41(10):1704-13. Review.

5.

Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.

Scherübl H, Bäder M, Fett U, Hamm B, Schmidt-Gayk H, Koppenhagen K, Dop FJ, Riecken EO, Wiedenmann B.

Gastroenterology. 1993 Dec;105(6):1705-9.

PMID:
7902821
6.

Multiple effects of somatostatin analogs verified in three cases of metastasized neuroendocrine tumors of the gastroenteropancreatic system.

Biliotti G, Martini F, Vaggelli L, Messerini L, Colagrande S, Pupi A, Seghi P.

Tumori. 2006 Mar-Apr;92(2):170-4.

PMID:
16724698
7.

[Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].

Faiss S, Scherübl H, Bäder M, Fett U, Koppenhagen K, Wiedenmann B, Riecken EO.

Z Gastroenterol. 1994 May;32(5):243-6. German.

PMID:
7915450
8.

[PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

Scheidhauer K, Miederer M, Gaertner FC.

Radiologe. 2009 Mar;49(3):217-23. doi: 10.1007/s00117-008-1784-9. Review. German.

PMID:
19296068
9.

Somatostatin receptor scintigraphy in the diagnosis of neuroendocrine gastroenteropancreatic tumors.

Bäder M, Koppenhagen K.

Recent Results Cancer Res. 1996;142:137-62. Review.

PMID:
8893340
10.

Radiolabeled peptides in diagnosis and tumor imaging: clinical overview.

Warner RR, O'dorisio TM.

Semin Nucl Med. 2002 Apr;32(2):79-83. Review.

PMID:
11965602
11.

Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors.

Kvols LK.

Gastroenterology. 1993 Dec;105(6):1909-11. No abstract available.

PMID:
7902824
12.

Somatostatin receptor targeting for tumor imaging and therapy.

Grötzinger C, Wiedenmann B.

Ann N Y Acad Sci. 2004 Apr;1014:258-64. Review.

PMID:
15153442
13.

Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.

Balon HR, Goldsmith SJ, Siegel BA, Silberstein EB, Krenning EP, Lang O, Donohoe KJ; Society of Nuclear Medicine.

J Nucl Med. 2001 Jul;42(7):1134-8. No abstract available.

15.

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.

Van Essen M, Krenning EP, De Jong M, Valkema R, Kwekkeboom DJ.

Acta Oncol. 2007;46(6):723-34. Review.

PMID:
17653893
16.

[The role of echoendoscopy and scintigraphy of somatostatin receptors in the staging of neuro-endocrine digestive tumors].

Giovannini M, Pasquier J, Brenot-Rossi I, Perrier H, Sauvan R, Seitz JF.

Ann Gastroenterol Hepatol (Paris). 1995 Mar-Apr;31(2):109-13. Review. French. No abstract available.

PMID:
7618832
17.

Intraoperative gamma probe detection of neuroendocrine tumors.

Adams S, Baum RP, Hertel A, Wenisch HJ, Staib-Sebler E, Herrmann G, Encke A, Hör G.

J Nucl Med. 1998 Jul;39(7):1155-60.

18.

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.

Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, Mignon M, le Guludec D.

J Nucl Med. 1997 Jun;38(6):853-8.

19.

Current status and perspectives in peptide receptor radiation therapy.

Ansquer C, Kraeber-Bodéré F, Chatal JF.

Curr Pharm Des. 2009;15(21):2453-62. Review.

PMID:
19601842
20.

Preferential localization of regional metastases from gastroenteropancreatic endocrine tumors with somatostatin-receptor scintigraphy.

MacGillivray DC, Mumtaz MA, Kurtzman SH, Spencer RP, Weiner RE, Malchoff CD.

Arch Surg. 1996 Dec;131(12):1338-42.

PMID:
8956777

Supplemental Content

Support Center